Bahrajn -
angielski -
الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين
epaxal berna injection 0.5 ml
wael pharmacy - hepatitis a virus vaccine - injection - 0.5
Wielka Brytania -
angielski -
MHRA (Medicines & Healthcare Products Regulatory Agency)
epaxal vaccine emulsion for injection 0.5ml pre-filled syringes
janssen-cilag ltd - hepatitis a virus inactivated - emulsion for injection
Nowa Zelandia -
angielski -
Medsafe (Medicines Safety Authority)
epaxal
pharmabroker sales ltd - hepatitis a vaccine 500 ria u (at least per 0.5ml dose) - suspension for injection - 500 ria u - active: hepatitis a vaccine 500 ria u (at least per 0.5ml dose) excipient: formaldehyde influenza virus a/singapore/6/86 phospholipids sodium chloride as solution, up to 0.5ml
Szwecja -
angielski -
Läkemedelsverket (Medical Products Agency)
epaxal injektionsvätska, suspension, förfylld spruta
Irlandia -
angielski -
HPRA (Health Products Regulatory Authority)
epaxal suspension for injection
crucell italy s.r.l. - hepatitis a virus (strain rg-sb) - suspension for injection
Irlandia -
angielski -
HPRA (Health Products Regulatory Authority)
epaxal %v/v suspension for injection
crucell italy s.r.l. - hepatitis a virus (strain rg-sb) - suspension for injection - %v/v
Izrael -
angielski -
Ministry of Health
epaxal
droreth ltd - hepatitis a antigen 24 iu / 0.5 ml - solution for injection - hepatitis a, inactivated, whole virus - active immunization against hepatitis a for adults and children age 1 year and above.
Kanada -
angielski -
Health Canada
epaxal liquid
berna biotech ltd - hepatitis a vaccine, inactivated - liquid - 500unit - hepatitis a vaccine, inactivated 500unit - vaccines
Wielka Brytania -
angielski -
MHRA (Medicines & Healthcare Products Regulatory Agency)
epaxal berna injection 0.5ml pre-filled syringes
masta ltd - hepatitis a virus inactivated - suspension for injection
Unia Europejska -
angielski -
EMA (European Medicines Agency)
epoetin alfa hexal
hexal ag - epoetin alfa - anemia; kidney failure, chronic; cancer - antianemic preparations - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. , treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre-existing anaemia at the start of chemotherapy).,